ANGLE announces collaboration with Myriad Genetics | 20-Aug-2025 | 07:00 | RNS |
Result of 2025 Annual General Meeting | 30-Jun-2025 | 17:50 | RNS |
POSTING OF ANNUAL REPORT AND NOTICE OF AGM | 09-Jun-2025 | 07:00 | RNS |
Board Changes | 06-Jun-2025 | 07:00 | RNS |
Preliminary Results | 28-May-2025 | 07:00 | RNS |
Notice of Results | 23-May-2025 | 07:00 | RNS |
Issue of LTIP Options and Share Options | 21-Mar-2025 | 07:00 | RNS |
Results of Eisai Phase 2 pilot study | 21-Mar-2025 | 07:00 | RNS |
Analysis of CTC-DNA and ctDNA using Illumina assay | 29-Jan-2025 | 07:00 | RNS |
Trading Update | 23-Jan-2025 | 07:00 | RNS |
Half-year Report | 26-Sep-2024 | 07:00 | RNS |
Exclusive agreement for DNA NGS panel | 23-Sep-2024 | 07:00 | RNS |
Notice of Interim Results and Webcast | 17-Sep-2024 | 07:00 | RNS |
Standard form for notification of major holdings | 18-Jul-2024 | 10:08 | RNS |
Standard form for notification of major holdings | 12-Jul-2024 | 15:38 | RNS |
Currency | UK Pounds |
Share Price | 6.50p |
Change Today | 0.25p |
% Change | 4.00 % |
52 Week High | 16.50p |
52 Week Low | 5.00p |
Volume | 678,645 |
Shares Issued | 322.64m |
Market Cap | £20.97m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
17:05 | 55,000 @ 6.50p |
14:25 | 10,265 @ 6.78p |
14:15 | 19,019 @ 6.83p |
13:37 | 5,010 @ 6.33p |
13:35 | 235 @ 7.00p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research